UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 627

Sortiert nach

Targeting abnormal DNA double-strand break repair in tyrosine kinase inhibitor-resistant chronic myeloid leukemias

Oncogene, 2013-04, Vol.32 (14), p.1784-1793

2013

Link zum Volltext

Verfügbarkeit prüfen

Randomized multicenter phase II study of flavopiridol (alvocidib), cytarabine, and mitoxantrone (FLAM) versus cytarabine/daunorubicin (7+3) in newly diagnosed acute myeloid leukemia

Haematologica (Roma), 2015-09, Vol.100 (9), p.1172

2015

Link zum Volltext

Verfügbarkeit prüfen

Loss of the mismatched human leukocyte antigen haplotype in two acute myelogenous leukemia relapses after haploidentical bone marrow transplantation with post-transplantation cyclophosphamide

Leukemia, 2016-10, Vol.30 (10), p.2102-2106

2016

Link zum Volltext

Verfügbarkeit prüfen

CHK1 and WEE1 inhibition combine synergistically to enhance therapeutic efficacy in acute myeloid leukemia ex vivo

Haematologica (Roma), 2014-04, Vol.99 (4), p.688

2014

Link zum Volltext

Verfügbarkeit prüfen

Phase I study of the heat shock protein 90 inhibitor alvespimycin (KOS-1022, 17-DMAG) administered intravenously twice weekly to patients with acute myeloid leukemia

Leukemia, 2010-04, Vol.24 (4), p.699-705

2010

Link zum Volltext

Verfügbarkeit prüfen

Glans penis involvement: an under-recognized manifestation of chronic GVHD

Bone marrow transplantation (Basingstoke), 2012-07, Vol.47 (7), p.1006-1007

2012

Link zum Volltext

Verfügbarkeit prüfen

A novel NUP98-PHF23 fusion resulting from a cryptic translocation t(11;17)(p15;p13) in acute myeloid leukemia

Leukemia, 2007-04, Vol.21 (4), p.842-844

2007

Link zum Volltext

Verfügbarkeit prüfen

Activation of a novel palmitoyltransferase ZDHHC14 in acute biphenotypic leukemia and subsets of acute myeloid leukemia

Leukemia, 2011-02, Vol.25 (2), p.367-371

2011

Link zum Volltext

Verfügbarkeit prüfen

Durable complete remission after single agent decitabine in AML relapsing in extramedullary sites after allo-SCT

Bone marrow transplantation (Basingstoke), 2012-07, Vol.47 (7), p.1008-1009

2012

Link zum Volltext

Verfügbarkeit prüfen

Granulomatous amebic encephalitis: an under‐recognized cause of infectious mortality after hematopoietic stem cell transplantation

Transplant infectious disease, 2011-08, Vol.13 (4), p.366-373

2011

Link zum Volltext

Verfügbarkeit prüfen

A Phase I Trial of Ipilimumab (IPI) in Patients (PTS) with Myelodysplastic Syndromes (MDS) after Hypomethylating Agent (HMAS) Failure

Leukemia research, 2017-04, Vol.55, p.S43-S43

2017

Link zum Volltext

Verfügbarkeit prüfen

High-dose cyclophosphamide with or without etoposide for mobilization of peripheral blood progenitor cells in patients with multiple myeloma: efficacy and toxicity

Bone marrow transplantation (Basingstoke), 2004-07, Vol.34 (1), p.69-76

2004

Link zum Volltext

Verfügbarkeit prüfen

A Signature of T Cell Exhaustion Is Enriched in the Bone Marrow (BM) of AML Patients and Shared with Immune Exhaustion Signatures of Solid Tumors

BLOOD, 2019-11, Vol.134 (Supplement_1), p.2711-2711

2019

Link zum Volltext

Verfügbarkeit prüfen

Autologous stem cell transplantation followed by consolidation chemotherapy for patients with multiple myeloma

Bone marrow transplantation (Basingstoke), 2006-01, Vol.37 (1), p.65-72

2006

Link zum Volltext

Verfügbarkeit prüfen

A phase II trial of sequential ribonucleotide reductase inhibition in aggressive myeloproliferative neoplasms

Haematologica (Roma), 2014-04, Vol.99 (4), p.672

2014

Link zum Volltext

Verfügbarkeit prüfen

Pulmonary toxicity syndrome following CDEP (cyclophosphamide, dexamethasone, etoposide, cisplatin) chemotherapy

Bone marrow transplantation (Basingstoke), 2001-08, Vol.28 (4), p.399-403

2001

Link zum Volltext

Verfügbarkeit prüfen

The impact of biology on the treatment of secondary AML

Cancer treatment and research, 2001, Vol.108, p.231

2001

Link zum Volltext

Verfügbarkeit prüfen

64 - A Phase I Trial of Ipilimumab (IPI) in Patients (PTS) with Myelodysplastic Syndromes (MDS) after Hypomethylating Agent (HMAS) Failure

Leukemia research, 2017-04, Vol.55, p.S43-S43

2017

Link zum Volltext

Verfügbarkeit prüfen

von Willebrand Factor–Cleaving Protease in Thrombotic Thrombocytopenic Purpura and the Hemolytic–Uremic Syndrome

The New England journal of medicine, 1999-04, Vol.340 (17), p.1368-1369

1999

Link zum Volltext

Verfügbarkeit prüfen

Integrated analysis of CRLF2 signaling in acute lymphoblastic leukemia identifies Polo-like kinase 1 as a potential therapeutic target

Leukemia & lymphoma, 2015-05, Vol.56 (5), p.1524-1527

2015

Link zum Volltext

Verfügbarkeit prüfen

Treatment of human immunodeficiency virus (HIV)–associated Burkitt lymphoma (BL) in the era of combined antiretroviral therapy (cART) and rituximab

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.e18521-e18521

2011

Link zum Volltext

Verfügbarkeit prüfen

Subdural hematomas in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia receiving imatinib mesylate in conjunction with multi-agent chemotherapy

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.6579-6579

2011

Link zum Volltext

Verfügbarkeit prüfen

Race and overall survival in acute myeloid leukemia

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.6570-6570

2010

Link zum Volltext

Verfügbarkeit prüfen

A phase II study of timed sequential therapy of acute myelogenous leukemia (AML) for patients over the age of 60: two cycle timed sequential therapy with topotecan, ara-C and mitoxantrone in adults with poor-risk AML

Leukemia research, 2004-06, Vol.28 (6), p.571-577

2004

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 627

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(573)
Mit Volltextzugriff
(576)

Publikationsform

Sprache

Englisch
(624)
Japanisch
(72)
Croatian
(5)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Targeting abnormal DNA double-strand break repair in tyrosine kinase inhibitor-resistant chronic myeloid leukemias

Randomized multicenter phase II study of flavopiridol (alvocidib), cytarabine, and mitoxantrone (FLAM) versus cytarabine/daunorubicin (7+3) in newly diagnosed acute myeloid leukemia

Loss of the mismatched human leukocyte antigen haplotype in two acute myelogenous leukemia relapses after haploidentical bone marrow transplantation with post-transplantation cyclophosphamide

CHK1 and WEE1 inhibition combine synergistically to enhance therapeutic efficacy in acute myeloid leukemia ex vivo

Phase I study of the heat shock protein 90 inhibitor alvespimycin (KOS-1022, 17-DMAG) administered intravenously twice weekly to patients with acute myeloid leukemia

Glans penis involvement: an under-recognized manifestation of chronic GVHD

A novel NUP98-PHF23 fusion resulting from a cryptic translocation t(11;17)(p15;p13) in acute myeloid leukemia

Activation of a novel palmitoyltransferase ZDHHC14 in acute biphenotypic leukemia and subsets of acute myeloid leukemia

Durable complete remission after single agent decitabine in AML relapsing in extramedullary sites after allo-SCT

Granulomatous amebic encephalitis: an under‐recognized cause of infectious mortality after hematopoietic stem cell transplantation

A Phase I Trial of Ipilimumab (IPI) in Patients (PTS) with Myelodysplastic Syndromes (MDS) after Hypomethylating Agent (HMAS) Failure

High-dose cyclophosphamide with or without etoposide for mobilization of peripheral blood progenitor cells in patients with multiple myeloma: efficacy and toxicity

A Signature of T Cell Exhaustion Is Enriched in the Bone Marrow (BM) of AML Patients and Shared with Immune Exhaustion Signatures of Solid Tumors

Autologous stem cell transplantation followed by consolidation chemotherapy for patients with multiple myeloma

A phase II trial of sequential ribonucleotide reductase inhibition in aggressive myeloproliferative neoplasms

Clinical and biologic activity of the farnesyltransferase inhibitor R115777 in adults with refractory and relapsed acute leukemias: a phase 1 clinical-laboratory correlative trial

Pulmonary toxicity syndrome following CDEP (cyclophosphamide, dexamethasone, etoposide, cisplatin) chemotherapy

The impact of biology on the treatment of secondary AML

64 - A Phase I Trial of Ipilimumab (IPI) in Patients (PTS) with Myelodysplastic Syndromes (MDS) after Hypomethylating Agent (HMAS) Failure

von Willebrand Factor–Cleaving Protease in Thrombotic Thrombocytopenic Purpura and the Hemolytic–Uremic Syndrome

Integrated analysis of CRLF2 signaling in acute lymphoblastic leukemia identifies Polo-like kinase 1 as a potential therapeutic target

Treatment of human immunodeficiency virus (HIV)–associated Burkitt lymphoma (BL) in the era of combined antiretroviral therapy (cART) and rituximab

Subdural hematomas in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia receiving imatinib mesylate in conjunction with multi-agent chemotherapy

Race and overall survival in acute myeloid leukemia

A phase II study of timed sequential therapy of acute myelogenous leukemia (AML) for patients over the age of 60: two cycle timed sequential therapy with topotecan, ara-C and mitoxantrone in adults with poor-risk AML

Suchergebnisse filtern